Kelly W. Elliott, RN, MS
Founder, President, and CEO of Eminence Clinical Research, Inc.
Ms. Elliott founded Eminence Clincial Research, Inc. to accomplish two primary objectives:
- Facilitate the introduction of cutting-edge technologies to patients through research and expedite new device clearances/approvals.
- Enhance research initiatives by equipping physicians with the expertise and resources needed to conduct rigorous, industry-independent studies.
Ms. Elliot’s career is distinguished by a steadfast commitment to excellence. Drawing from a robust clinical background in medical-surgical and open heart ICUs, as well as the cardiac catheterization lab, she possesses unique insight into designing and executing clinical trials across diverse medical disciplines.
Throughout her tenure, Ms. Elliott has occupied executive roles in several medical device firms, spearheading strategic clinical trial programs that yielded new device approvals, expanded indications, and numerous publications in esteemed peer-reviewed journals. Her work underscores the pivotal role of meticulous study design and execution in achieving corporate objectives and advancing medical innovation.
Our Family of Catheters
For restoring blood flow in peripheral and pulmonary vessels
The catheter’s expandable infusion basket allows a controlled and selective infusion of physician-specified fluids.
Available in 7F and 8F sizes.
For restoring blood flow within shorter peripheral and pulmonary vessels
The short basket of the S-B catheter allows navigation and implementation in shorter, more tortuous vessels.
Available in 7F and 8F sizes.
For restoring blood flow in peripheral vessels with extensive thrombus burden
A family of catheters designed to deliver thrombolytics through the expandable infusion basket and along a segment of the catheter shaft.
-